Dave Nellesen is a Vice President at Analysis Group, a leading economic consulting firm, and has broad experience in consulting, applying a range of strategies to commercialize products for the biotechnology, pharmaceutical, molecular diagnostics, and medical device industries. Dr. Nellesen specializes in helping clients prepare for market access and reimbursement challenges in the U.S. and other major markets. His work spans reimbursement strategy, economic analysis, and market and payer research. Projects are often designed to generate new evidence demonstrating the value of new technologies to payers, using health economic models, systematic reviews, evidence compendia, and value dossiers, often resulting in peer-reviewed publications. Dr. Nellesen has extensive experience in oncology, having supported the development, launch or commercialization of more than 10 currently marketed oncology products. Prior to joining Analysis Group, Dr. Nellesen worked for several years as senior scientist and manager at Incyte, and has more than 14 years’ experience in the biotechnology industry as a scientist and management consultant. Dr. Nellesen received his PhD from UCSD and his MBA from UC Berkeley (Haas).